Congo, Democratic Republic of the vs Eritrea: Antiretroviral therapy coverage
Congo, Democratic Republic of the
71.0%
in 2024
Eritrea
72.0%
in 2024
Congo, Democratic Republic of the rank
74th
Eritrea rank
72nd
Antiretroviral therapy coverage over time
- Congo, Democratic Republic of the
- Eritrea
How they compare
Eritrea currently reports 72.0% against 71.0% in Congo, Democratic Republic of the, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Eritrea ahead.
Congo, Democratic Republic of the ranks 74th and Eritrea ranks 72nd of 143 countries.
Eritrea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.8% | 5.2% | 3.4% | Eritrea |
| 2010s | 22.0% | 51.5% | 29.5% | Eritrea |
| 2020s | 65.2% | 70.6% | 5.4% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Congo, Democratic Republic of the or Eritrea?
- Eritrea, at 72.0% against 71.0% in Congo, Democratic Republic of the as of 2024.
- What is the difference in antiretroviral therapy coverage between Congo, Democratic Republic of the and Eritrea?
- 1.0%, with Eritrea ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Eritrea?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo, Democratic Republic of the and Eritrea rank globally for antiretroviral therapy coverage?
- Congo, Democratic Republic of the ranks 74th and Eritrea ranks 72nd of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.